CARD10 and hereditary clear cell renal cell carcinoma: Patients with renal cell carcinomas expressing high levels of CARMA3 had a significantly worse prognosis relative to patients with tumors of lower CARMA3 expression, indicating the possible utility of CARMA3 expression as a prognostic biomarker in renal cell carcinoma.